Cite
Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.
MLA
Mustafayev, Fatma Nihan Akkoc, et al. “Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.” European Journal of Breast Health, vol. 19, no. 4, Oct. 2023, pp. 267–73. EBSCOhost, https://doi.org/10.4274/ejbh.galenos.2023.2023-7-3.
APA
Mustafayev, F. N. A., Liu, D. D., Gutierrez, A. M., Lewis, J. E., Ibrahim, N. K., Valero, V., Booser, D. J., Litton, J. K., Koenig, K., Dihua Yu, Sneige, N., & Arun, B. K. (2023). Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention. European Journal of Breast Health, 19(4), 267–273. https://doi.org/10.4274/ejbh.galenos.2023.2023-7-3
Chicago
Mustafayev, Fatma Nihan Akkoc, Diane D. Liu, Angelica M. Gutierrez, John E. Lewis, Nuhad K. Ibrahim, Vicente Valero, Daniel J. Booser, et al. 2023. “Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.” European Journal of Breast Health 19 (4): 267–73. doi:10.4274/ejbh.galenos.2023.2023-7-3.